Clinical Trials Logo

Gambling clinical trials

View clinical trials related to Gambling.

Filter by:

NCT ID: NCT05413564 Recruiting - Gambling Disorder Clinical Trials

Impact of a Self-Exclusion Procedure Optimized by an Extension of the Suspension of Commercial Solicitations

PASS
Start date: May 30, 2022
Phase: N/A
Study type: Interventional

Considering that self-exclusion from gambling on a particular website is an intervention for and by individuals who have developed a gambling disorder, it is currently exclusively a behavioural intervention in the sense that it prevents the behaviour Resumption of commercial solicitations only in the period when gambling is not accessible in the corresponding website , through voluntary self-exclusion (where the gambler prevents himself or herself from gambling), does not appear to be sufficient to prevent relapse. Early commercial solicitations, in the immediate intercourse after the end of the self-exlcusion period may precipitate relapse in gamblers whose behaviour change is by definition recent, and who have only received a behavioural measure. The investigators hypothesize an improved efficacy as measured by reduced gambling after a self-exclusion optimized by a period of suspension of commercial solicitations extended to 9 months, compared to self-exclusion with the standard procedure. Gamblers will be randomized according to an a priori randomization list.

NCT ID: NCT05331612 Not yet recruiting - Gambling Disorder Clinical Trials

Blended Treatment for Problem Gambling and Gambling Disorder Combining Group Sessions and Online Modules

Start date: October 2022
Phase: N/A
Study type: Interventional

The main objective of present project is assess the preliminary efficacy of a blended psychological intervention, by comparing the improvements in the CBT and waiting list control groups of an evidence-based treatment protocol for problems related to gambling applied in a blended format (sessions through an online protocol treatment combining with face-to-face group sessions), as well as to evaluate the opinion and acceptance of the intervention.

NCT ID: NCT05276193 Recruiting - Gambling Disorder Clinical Trials

GamReg Sweden - Quality Register for Gambling and Gaming Disorders

Start date: April 15, 2019
Phase:
Study type: Observational [Patient Registry]

This is a quality register for the monitoring of clinical assessment and treatment for gambling disorder and gaming disorder in Swedish health care. This register is held by Region Skåne, the health care organization of Skåne in southern Sweden, and administered by Register center South, which is associated with health care services in the southern regions of Sweden (the establishment of quality registers in Swedish health care relies upon a national legislation). Quality registers by themselves do not represent formal research projects. However, future research projects can use quality registers, such as the present one, as a data source for future research projects in case they are approved by an ethics authority. Clinical study variables collected in the register include the following (examples): - gender, age, occupation, living conditions - if applicable, types of gambling associated with the treatment needs - if applicable, type of problematic video gaming - type of referral to the present treatment contact - treatment history in psychiatry, social services, enforcement agency - history of suicidal behavior - alcohol and drugs problems requiring assessment or treatment - violence victimization - type of treatment provided to the patient

NCT ID: NCT05241041 Recruiting - Gambling Clinical Trials

Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms

Start date: September 13, 2021
Phase: N/A
Study type: Interventional

Objective The purpose of this study is to examine the effects of auricular acupressure and group counseling with positive psychology on gambling severity, withdrawal symptoms, and dopamine. Methods This study is a randomized controlled trial and has been performed at a University in South Korea. 180 gamblers and 60 non-gamblers will be recruited. In the first year, gamblers will be randomly assigned to two groups: Experimental Group 1 (auricular acupressure); and Control Group 1 (education material to stop and cope withdrawal symptoms). And Normal Group will be recruited independently. Furthermore, a single blind randomized controlled trial will be performed in second and third year. And gamblers will be randomly assigned to three groups: Experimental Group 2 (auricular acupressure + group counseling); Placebo Group (placebo acupressure + group counseling); and Control Group 2 (education material to stop and cope withdrawal symptoms). Auricular acupressure using acupellets is performed for 6 weeks continuously.

NCT ID: NCT05084885 Completed - Problem Gambling Clinical Trials

The Context of Gambling Treatment: Towards Creating an Online Service to Reduce Problem Gambling - Part Five

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

This application involves a multi-stage study with the ultimate goal of developing an online treatment service for problem gamblers. We will recruit up to 100 problem gamblers, and offer problem gambling treatment services to them entirely over the internet. The program will be evaluated based on uptake, experience of the participants, and pre-test vs post-test differences in gambling and well-being.

NCT ID: NCT05051085 Completed - Clinical trials for Pathological Gambling

Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

This uncontrolled feasibility pilot study explores the feasibility of a 10 week, 8-module, therapist-assisted, internet-delivered treatment program, "SpilleFri", for patients with Pathological Gambling. The study includes 25-30 participants aged 18-60 fulfilling diagnostic criteria for Pathological Gambling (ICD-10). The focus of the feasibility trial is evaluation of treatment response, treatment satisfaction, program utility, recruitment and retention rates, data completion rates, and time requirement. The primary feasibility criterion is 60 % of participants included in the study completing the treatment program.

NCT ID: NCT05016479 Not yet recruiting - Gambling Clinical Trials

Accelerated rTMS in Gambling Disorder: a Multicentric, Randomized, Sham-controlled Trial

arTMSinGD
Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Background: Gambling disorder (GD), is a behavioral addiction based on keeping play despite medical, economic and social consequences. GD is characterized by progressive and persistent brain circuits alterations (reward, stress, memory, impulse control and cognitive functions), so a possible treatment could be based on neuromodulation of specific brain areas. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation, which provides magnetic stimuli on certain brain areas parts with short and long-term effects. rTMS has the FDA approval for some neurological (headache) and psychiatric (treatment-resistant depression, obsessive-compulsive disorder) disease. Nowadays several evidence in scientific literature lead to a promise use of rTMS also in addiction field with a possible indication also for GD. Objectives: the main outcome is to assess symptoms related to GD (craving, play frequencies, money lost) before and after rTMS stimulation on left dorsolateral prefrontal cortex (DLPFC). Eligibility: Healthy, right-handed adults ages 18-65 with a diagnosis of GD. Design: This is a randomized, sham-controlled study. The study includes two phases:1) a rTMS continued treatment phase and 2) a follow-up without rTMS stimulation (30 days). In order to be enrolled, participants will be screened with: - Questionnaires - Medical history - Physical exam - f-MRI After being enrolled, baseline behavioral and imaging data will be collected. In particular, participants will submit: - Questionnaires - Functional MRI - Cognitive tasks During the continued rTMS phase, participants with gambling disorder will be randomized to receive real or sham rTMS. RTMS will be delivered during 5 outpatient treatment days, (3 times/die). After the last stimulation and at the end of the 30-days of follow-up period, subjects will undergo the neurocognitive and psychometric evaluation. Twenty randomized patients of whole enrolled group will undergo fMRI at baseline and at the end of arTMS treatment phase. Treatment includes: - rTMS: A weak electrical current passes through a coil placed on the head. During each stimulation day, participants will receive three rTMS sessions (13 min), with a 50 min of interval. - fMRI: Participants lie on a table that slides into a cylinder that takes pictures of the brain. They respond to images while in the scanner. - Repeat of screening tests and questionnaires

NCT ID: NCT04842461 Completed - Depression Clinical Trials

Mental Health, Addictions and Biomarkers in High Athletes Performance

Start date: October 15, 2020
Phase:
Study type: Observational [Patient Registry]

Sport is a privileged area to promote socialization and health values, such as companionship; a healthy lifestyle; cooperation to achieve common goals, and justice, rejecting unjustified advantages in competition. The concept of fair play is on which the development of those values pivots. From a holistic perspective, it is possible to define fair play, not only as a way to participate but also as a way of projecting people in life with values, assuming a set of behaviors that enhance a healthy and respectful sporting experience with opponents, the companions, the spectators, the referees and all the agents that take part in the sport practice.

NCT ID: NCT04811807 Not yet recruiting - Parkinson Disease Clinical Trials

Clinical Response of Impulsivity After Brain Stimulation in Parkinson's Disease

CRIPS
Start date: October 2021
Phase:
Study type: Observational [Patient Registry]

The objective of this prospective observational cohort study is to answer the following clinically important questions: 1. In patients with a pre-operative history of ICBs, what is the likelihood of improvement or deterioration in ICBs post-operatively? 2. What is the risk of developing post-operative de novo ICBs after Subthalamic Nucleus DBS (STN DBS)? 3. Which factors are important in predicting changes in ICBs after STN DBS? 4. What is the impact of ICBs on carer's quality of life QoL and burden?

NCT ID: NCT04738773 Not yet recruiting - Gambling Disorder Clinical Trials

RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response

Start date: June 1, 2021
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to determine whether favorable response to naltrexone orally taken in treatment of GD can be predicted by patterns of visual scanning, assessed by eye-tracking technology before, at the start and throughout gambling treatment with naltrexone.